FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Maria Vincenza Carriero

Research Profile

Chemicals & Drugs

Physiology

Disorders

Breast Neoplasms

Anatomy

Living Beings

Mouse

Procedures

Phenomena

Blotting, Western

Co-author Network

Publications

TOP 3
V Tirino; G Rocco; G Sessa; K Bifulco; R Camerlingo; Maria Vincenza Carriero; E Irollo; R Montella; N Normanno; F Paino; G Pirozzi
TGF-β1 exposure induces epithelial to mesenchymal transition both in CSCs and non-CSCs of the A549 cell line, leading to an increase of migration ability in the CD133(+) A549 cell fraction.
Katia Bifulco; Claudio Arra; Gioconda Di Carluccio; Paola Franco; Immacolata Longanesi Cattani; Maria Teresa Masucci; Pietro Mugione; Vincenzo Pavone; Giuseppe Pirozzi; Maria Patrizia Stoppelli; Maria Vincenza Carriero
Single amino acid substitutions in the chemotactic sequence of urokinase receptor modulate cell migration and invasion.
Nunzia Montuori; Ada Pesapane; Daniela Alfano; Katia Bifulco; Maria Vincenza Carriero; Claudio La Penna; Francesca Wanda Rossi; Guido Rossi; Salvatore Salzano; Valeria Visconte; Pia Ragno
The cross-talk between the urokinase receptor and fMLP receptors regulates the activity of the CXCR4 chemokine receptor.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Maria Vincenza Carriero (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: V Tirino; G Rocco; G Sessa; K Bifulco; R Camerlingo; Maria Vincenza Carriero; E Irollo; R Montella; N Normanno; F Paino; G Pirozzi
TGF-β1 exposure induces epithelial to mesenchymal transition both in CSCs and non-CSCs of the A549 cell line, leading to an increase of migration ability in the CD133(+) A549 cell fraction.
Cell death & disease 2013;4():e620.
2012: Katia Bifulco; Claudio Arra; Gioconda Di Carluccio; Paola Franco; Immacolata Longanesi Cattani; Maria Teresa Masucci; Pietro Mugione; Vincenzo Pavone; Giuseppe Pirozzi; Maria Patrizia Stoppelli; Maria Vincenza Carriero
Single amino acid substitutions in the chemotactic sequence of urokinase receptor modulate cell migration and invasion.
PloS one 2012;7(9):e44806.
2011: Nunzia Montuori; Ada Pesapane; Daniela Alfano; Katia Bifulco; Maria Vincenza Carriero; Claudio La Penna; Francesca Wanda Rossi; Guido Rossi; Salvatore Salzano; Valeria Visconte; Pia Ragno
The cross-talk between the urokinase receptor and fMLP receptors regulates the activity of the CXCR4 chemokine receptor.
Cellular and molecular life sciences : CMLS 2011;68(14):2453-67.
2011: Maria Vincenza Carriero; Maria Patrizia Stoppelli
The urokinase-type plasminogen activator and the generation of inhibitors of urokinase activity and signaling.
Current pharmaceutical design 2011;17(19):1944-61.
2011: Katia Bifulco; Immacolata Longanesi Cattani; Maria Teresa Masucci; Anna De Chiara; Flavio Fazioli; Gioconda Di Carluccio; Giuseppe Pirozzi; Michele Gallo; Antonello La Rocca; Gaetano Apice; Gaetano Rocco; Maria Vincenza Carriero
Involvement of the soluble urokinase receptor in chondrosarcoma cell mobilization.
Sarcoma 2011;2011():842842.
2010: K Bifulco; Immacolata Longanesi Cattani; M Gala; G DI Carluccio; M T Masucci; V Pavone; L Lista; C Arra; Maria Patrizia Stoppelli; Maria Vincenza Carriero
The soluble form of urokinase receptor promotes angiogenesis through its Ser⁸⁸-Arg-Ser-Arg-Tyr⁹² chemotactic sequence.
Journal of thrombosis and haemostasis : JTH 2010;8(12):2789-99.
2009: Maria Vincenza Carriero; Immacolata Longanesi Cattani; Katia Bifulco; Ornella Maglio; Liliana Lista; Antonio Barbieri; Giuseppina Votta; Maria Teresa Masucci; Claudio Arra; renato franco; Mario De Rosa; Maria Patrizia Stoppelli; Vincenzo Pavone
Structure-based design of an urokinase-type plasminogen activator receptor-derived peptide inhibiting cell migration and lung metastasis.
Molecular cancer therapeutics 2009;8(9):2708-17.
2009: Adone Baroni; Giovanna Donnarumma; Iole Paoletti; Immacolata Longanesi Cattani; Katia Bifulco; Maria Antonietta Tufano; Maria Vincenza Carriero
Antimicrobial human beta-defensin-2 stimulates migration, proliferation and tube formation of human umbilical vein endothelial cells.
Peptides 2009;30(2):267-72.
2009: Immacolata Vocca; Paola Franco; Daniela Alfano; Giuseppina Votta; Maria Vincenza Carriero; Yeriel Estrada; Mario Caputi; Paolo A Netti; Liliana Ossowski; Maria Patrizia Stoppelli
Inhibition of migration and invasion of carcinoma cells by urokinase-derived antagonists of alphavbeta5 integrin activation.
International journal of cancer. Journal international du cancer 2009;124(2):316-25.
2008: Katia Bifulco; Annarosaria De Chiara; Flavio Fazioli; Immacolata Longanesi Cattani; Anna Rita Cantelmo; Virginia Tirino; Gaetano Apice; Gaetano Rocco; Maria Luisa Lombardi; Maria Vincenza Carriero
Cell invasiveness in sarcomas: a possibly useful clinical correlation.
Tumori 2008;94(4):505-10.
2008: Katia Bifulco; Immacolata Longanesi Cattani; Lucia Gargiulo; Ornella Maglio; mauro cataldi; Mario De Rosa; Maria Patrizia Stoppelli; Vincenzo Pavone; Maria Vincenza Carriero
An urokinase receptor antagonist that inhibits cell migration by blocking the formyl peptide receptor.
FEBS letters 2008;582(7):1141-6.
2006: Carmine Selleri; Nunzia Montuori; Patrizia Ricci; Valeria Visconte; Antonio Baiano; Maria Vincenza Carriero; Bruno Rotoli; Guido Rossi; Pia Ragno
In vivo activity of the cleaved form of soluble urokinase receptor: a new hematopoietic stem/progenitor cell mobilizer.
Cancer research 2006;66(22):10885-90.
2006: Carmine Selleri; Pia Ragno; Patrizia Ricci; Valeria Visconte; Nicola Scarpato; Maria Vincenza Carriero; Bruno Rotoli; Guido Rossi; Nunzia Montuori
The metastasis-associated 67-kDa laminin receptor is involved in G-CSF-induced hematopoietic stem cell mobilization.
Blood 2006;108(7):2476-84.
2006: Paola Franco; Immacolata Vocca; Maria Vincenza Carriero; Daniela Alfano; Letizia Cito; Immacolata Longanesi Cattani; Paolo Grieco; Liliana Ossowski; Maria Patrizia Stoppelli
Activation of urokinase receptor by a novel interaction between the connecting peptide region of urokinase and alpha v beta 5 integrin.
Journal of cell science 2006;119(Pt 16):3424-34.
2005: Lucia Gargiulo; Immacolata Longanesi Cattani; Katia Bifulco; Paola Franco; Rosanna Raiola; Pietro Campiglia; Paolo Grieco; Gianfranco Peluso; Maria Patrizia Stoppelli; Maria Vincenza Carriero
Cross-talk between fMLP and vitronectin receptors triggered by urokinase receptor-derived SRSRY peptide.
The Journal of biological chemistry 2005;280(26):25225-32.
2005: Carmine Selleri; Nunzia Montuori; Patrizia Ricci; Valeria Visconte; Maria Vincenza Carriero; Nicolai Sidenius; Bianca Serio; Francesco Blasi; Bruno Rotoli; Guido Rossi; Pia Ragno
Involvement of the urokinase-type plasminogen activator receptor in hematopoietic stem cell mobilization.
Blood 2005;105(5):2198-205.
2005: Daniela Alfano; Paola Franco; Immacolata Vocca; Nadia Gambi; Viviana Pisa; Alessandro Mancini; Mario Caputi; Maria Vincenza Carriero; Ingram Iaccarino; Maria Patrizia Stoppelli
The urokinase plasminogen activator and its receptor: role in cell growth and apoptosis.
Thrombosis and haemostasis 2005;93(2):205-11.
2004: Nicola Normanno; Antonella De Luca; Caterina Bianco; Monica R Maiello; Maria Vincenza Carriero; Aasia Rehman; Christian Wechselberger; Claudio Arra; Luigi Strizzi; Michele Sanicola; David S Salomon
Cripto-1 overexpression leads to enhanced invasiveness and resistance to anoikis in human MCF-7 breast cancer cells.
Journal of cellular physiology 2004;198(1):31-9.
2003: Adone Baroni; Iole Paoletti; I Silvestri; Elisabetta Buommino; Maria Vincenza Carriero
Early vitronectin receptor downregulation in a melanoma cell line during all-trans retinoic acid-induced apoptosis.
The British journal of dermatology 2003;148(3):424-33.
2002: Immacolata Silvestri; Immacolata Longanesi Cattani; Paola Franco; Giuseppe Pirozzi; Gerardo Botti; Maria Patrizia Stoppelli; Maria Vincenza Carriero
Engaged urokinase receptors enhance tumor breast cell migration and invasion by upregulating alpha(v)beta5 vitronectin receptor cell surface expression.
International journal of cancer. Journal international du cancer 2002;102(6):562-71.
2002: Nunzia Montuori; Maria Vincenza Carriero; Salvatore Salzano; Guido Rossi; Pia Ragno
The cleavage of the urokinase receptor regulates its multiple functions.
The Journal of biological chemistry 2002;277(49):46932-9.
2002: Maria Vincenza Carriero; Paola Franco; Lucia Gargiulo; Immacolata Vocca; Letizia Cito; Laura Fontana; Ciro Iaccarino; Giovanna Del Pozzo; John Guardiola; Maria Patrizia Stoppelli
Inhibition of receptor-dependent urokinase signaling by specific Ser to Glu substitutions.
Biological chemistry 2002;383(1):107-13.
2001: Ciro Indolfi; Daniele Torella; Luigi Cavuto; Alberto M Davalli; Carmela Coppola; Giovanni Esposito; Maria Vincenza Carriero; Antonio Rapacciuolo; Emilio Di Lorenzo; Eugenio Stabile; Cinzia Perrino; A Chieffo; F Pardo; Massimo Chiariello
Effects of balloon injury on neointimal hyperplasia in streptozotocin-induced diabetes and in hyperinsulinemic nondiabetic pancreatic islet-transplanted rats.
Circulation 2001;103(24):2980-6.
2000: Antonella Zannetti; Silvana Del Vecchio; Maria Vincenza Carriero; Rosa Fonti; Paola Franco; Gerardo Botti; Giuseppe D'Aiuto; Maria Patrizia Stoppelli; Marco Salvatore
Coordinate up-regulation of Sp1 DNA-binding activity and urokinase receptor expression in breast carcinoma.
Cancer research 2000;60(6):1546-51.
1999: Maria Vincenza Carriero; Silvana Del Vecchio; M Capozzoli; Paola Franco; L Fontana; Antonella Zannetti; Gerardo Botti; Giuseppe D'Aiuto; Marco Salvatore; Maria Patrizia Stoppelli
Urokinase receptor interacts with alpha(v)beta5 vitronectin receptor, promoting urokinase-dependent cell migration in breast cancer.
Cancer research 1999;59(20):5307-14.
1999: F Chiaradonna; L Fontana; C Iavarone; Maria Vincenza Carriero; G Scholz; M V Barone; Maria Patrizia Stoppelli
Urokinase receptor-dependent and -independent p56/59(hck) activation state is a molecular switch between myelomonocytic cell motility and adherence.
The EMBO journal 1999;18(11):3013-23.
1998: Andrea Ciarmiello; Silvana Del Vecchio; P Silvestro; MI Potena; Maria Vincenza Carriero; R Thomas; Gerardo Botti; Giuseppe D'Aiuto; Marco Salvatore
Tumor clearance of technetium 99m-sestamibi as a predictor of response to neoadjuvant chemotherapy for locally advanced breast cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1998;16(5):1677-83.
1997: Silvana Del Vecchio; Andrea Ciarmiello; Leonardo Pace; MI Potena; Maria Vincenza Carriero; Ciro Mainolfi; R Thomas; Giuseppe D'Aiuto; T Tsuruo; Marco Salvatore
Fractional retention of technetium-99m-sestamibi as an index of P-glycoprotein expression in untreated breast cancer patients.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1997;38(9):1348-51.
1997: Maria Vincenza Carriero; Silvana Del Vecchio; Paola Franco; MI Potena; F Chiaradonna; Gerardo Botti; Maria Patrizia Stoppelli; Marco Salvatore
Vitronectin binding to urokinase receptor in human breast cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 1997;3(8):1299-308.
1997: S D Vecchio; Andrea Ciarmiello; MI Potena; Maria Vincenza Carriero; Ciro Mainolfi; Gerardo Botti; R Thomas; M Cerra; Giuseppe D'Aiuto; T Tsuruo; Marco Salvatore
In vivo detection of multidrug-resistant (MDR1) phenotype by technetium-99m sestamibi scan in untreated breast cancer patients.
European journal of nuclear medicine 1997;24(2):150-9.
1996: P Y Li; Silvana Del Vecchio; R Fonti; Maria Vincenza Carriero; MI Potena; G Botti; Silvia Miotti; Secondo Lastoria; S Menard; MI Colnaghi; Marco Salvatore
Local concentration of folate binding protein GP38 in sections of human ovarian carcinoma by in vitro quantitative autoradiography.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1996;37(4):665-72.
1994: Maria Vincenza Carriero; Paola Franco; Silvana Del Vecchio; O Massa; Gerardo Botti; Giuseppe D'Aiuto; Maria Patrizia Stoppelli; Marco Salvatore
Tissue distribution of soluble and receptor-bound urokinase in human breast cancer using a panel of monoclonal antibodies.
Cancer research 1994;54(20):5445-54.
1994: Silvana Del Vecchio; Maria Patrizia Stoppelli; Maria Vincenza Carriero; R Fonti; O Massa; P Y Li; Gerardo Botti; M Cerra; Giuseppe D'Aiuto; G Esposito
In vitro receptor imaging for characterization of human solid tumors.
Nuclear medicine and biology 1994;21(5):771-4.
1993: Silvana Del Vecchio; Maria Patrizia Stoppelli; Maria Vincenza Carriero; R Fonti; O Massa; P Y Li; Gerardo Botti; M Cerra; Giuseppe D'Aiuto; G Esposito
Human urokinase receptor concentration in malignant and benign breast tumors by in vitro quantitative autoradiography: comparison with urokinase levels.
Cancer research 1993;53(13):3198-206.
1991: Maria Vincenza Carriero; A M Bevilacqua; A Borrelli; M Di Bonito; fabiana tatangelo; A Apicella
Ki-67 and B72.3 expression in breast cancer: an immunohistochemical study.
International journal of radiation applications and instrumentation. Part B, Nuclear medicine and biology 1991;18(1):95-9.
1984: R Rossiello; Maria Vincenza Carriero; A M Bevilacqua; M R Di Costanzo; M Di Bonito
[The secretory IgA system and breast cancer].
Pathologica 1984;76(1042):201-9.
1984: R Rossiello; Maria Vincenza Carriero; GG Giordano
Distribution of ferritin, transferrin and lactoferrin in breast carcinoma tissue.
Journal of clinical pathology 1984;37(1):51-5.